<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01065857</url>
  </required_header>
  <id_info>
    <org_study_id>CF-PICOS2006</org_study_id>
    <nct_id>NCT01065857</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.</brief_title>
  <official_title>Phase III, Multicenter, Randomized, Assessor-blind Study to Evaluate the Safety and Efficacy of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratorios Casen-Fleet S.L.U.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Trial Form Support S.L.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Apices Soluciones S.L.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laboratorios Casen-Fleet S.L.U.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine any significant differences in the efficacy and
      acceptability between CitraFleet and Klean Prep® (polyethylene glycol) for the preparation of
      gastrointestinal subjects undergoing a colon examination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The composite principal objective of the current study will therefore be, to determine any
      significant differences in the joint variable of efficacy and acceptability between
      CitraFleet and Klean Prep® (polyethylene glycol) for the preparation of subjects undergoing a
      colon examination.

      The evaluation will be carried out by two blinded assessors, independent of the investigator
      who performed the procedure (endoscopist investigator). It will be assessed from images of
      different sections of the colon: cecum, ascending, transverse, descending and rectum and
      subsequent confirmation by Principal Investigator if an agreement has been reached between
      the two blinded assessors or whether it is necessary to reach consensus.

      The evaluation of the subject's acceptability will be assessed using a 5 point scale which
      assesses the difficulty of taking the product, the degree of discomfort caused by it, and the
      taste of the drug.

      The secondary objective is to evaluate the safety of CitraFleet.

      In addition a second exploratory arm of CitraFleet was included in this study (CitraFleet
      Exploratory arm). The study is not powered to make formal statistical comparisons for this
      arm. Exploratory assessment of this arm against the main CitraFleet regimen and Klean-Prep
      will be made in order to run future trials design with this schedule.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of subjects that achieve 'excellent' or 'good' cleansing in the Fleet® Grading Scale for Bowel Cleansing.</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of subjects who find the agent easy to take or tolerable using a 5 point scale which assesses, the difficulty of taking the product, the degree of discomfort caused by it, and the taste of the drug, recorded in the subject questionnaire</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of adverse reactions.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">547</enrollment>
  <condition>Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.</condition>
  <arm_group>
    <arm_group_label>Citrafleet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The day prior to the colonoscopy in two dose times, first at 15:00h and second at 20:00h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Klean Prep</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The day prior to the colonoscopy from 16:00h to 20:00h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Citrafleet Exploratory</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The day of the colonoscopy in two dose times, first at 06:00h and second at 09:00h.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium picosulphate, light magnesium oxide and anhydride citric acid.</intervention_name>
    <description>2 Single-dose sachets containing sodium picosulphate (0.01g/sachet), light magnesium oxide (3.50g/sachet) and anhydrous citric acid (10.97g/sachet).</description>
    <arm_group_label>Citrafleet</arm_group_label>
    <arm_group_label>Citrafleet Exploratory</arm_group_label>
    <other_name>Citrafleet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate.</intervention_name>
    <description>4 sachets containing Polyethylene glycol 3350 (59 gr), KCl (0.7425 gr), NaCl (1.465 gr), sodium sulphate anhydrous (5.685 gr), sodium bicarbonate (1.685 gr).</description>
    <arm_group_label>Klean Prep</arm_group_label>
    <other_name>KleanPrep PEG 4l</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who are between 18 and 80 years of age.

          -  Subjects undergoing complete colonoscopy and therefore require prior preparation with
             either Klean Prep® or CitraFleet.

          -  Subjects capable of maintaining appropriate oral hydration during the intestinal
             preparation process.

          -  Subjects that have provided written informed consent.

          -  Subjects in whom the use of any of the study drugs (KleanPrep®,CitraFleet) is not
             contraindicated.

          -  Subjects who can communicate with the study personnel and comply with study
             requirements.

          -  Subjects undergoing a complete exploratory diagnostic colonoscopy for the first time.

        Exclusion Criteria:

          -  Severe renal insufficiency.

          -  Ascites.

          -  Congestive heart failure.

          -  Gastrointestinal obstruction, gastric retention, intestinal perforation and/or ileus.

          -  Megacolon and/or toxic colitis.

          -  Nausea and/or vomiting and/or abdominal pain.

          -  Severe dehydration.

          -  Hypermagnesemia.

          -  Rhabdomyolysis.

          -  Pregnant women.

          -  Subjects who have participated in a clinical trial in the previous 30 days.

          -  Abdominal surgery for any acute process (for example acute appendicitis).

          -  Active inflammatory intestinal disease.

          -  Known allergy to any of the active ingredients or excipients of the study drugs.

          -  Subjects not providing written informed consent.

          -  Subjects not complying with all of the inclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel A. Muñoz-Navas, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clínica Universitaria de Navarra</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H. Infanta Elena</name>
      <address>
        <city>Valdemoro</city>
        <state>Madrid</state>
        <zip>28340</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitario de Canarias</name>
      <address>
        <city>La Laguna</city>
        <state>Tenerife</state>
        <zip>38320</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Basurto</name>
      <address>
        <city>Bilbao</city>
        <state>Vizcaya</state>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitari Vall´d Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Clínic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. General Universitario Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitario Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Regional Universitario Carlos Haya</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Universitario La Fé</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2010</study_first_submitted>
  <study_first_submitted_qc>February 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2010</study_first_posted>
  <last_update_submitted>April 14, 2011</last_update_submitted>
  <last_update_submitted_qc>April 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ángel Navarro Lima, M.D. / European Medical Affairs Director</name_title>
    <organization>Laboratorios Casen-Fleet S.L.U.</organization>
  </responsible_party>
  <keyword>Colonoscopy, Preparation, Evacuating, Bowel Cleansing.</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
    <mesh_term>Sodium sulfate</mesh_term>
    <mesh_term>Magnesium Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

